Assess the data and tweets to estimate whether the closing price of $gild will escalate or deflate at 2017-03-23. Respond with either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-03-09,1.2,1.3,-0.8,-1.9,-1.9,1.8,2.3,2.1,1.2,1.8,2.4
2017-03-10,0.6,0.6,-1.1,-0.3,-0.3,1.3,2.3,2.2,1.7,1.9,2.5
2017-03-13,0.3,0.4,-0.8,-0.1,-0.1,0.9,2.1,2.1,1.9,1.8,2.5
2017-03-14,-0.5,0.5,-0.5,-0.5,0.3,0.4,1.5,1.8,1.7,1.3,2.1
2017-03-15,-0.7,0.5,-1.3,1.0,1.0,-0.9,0.3,0.7,0.8,-0.0,0.9
2017-03-16,0.3,0.4,-0.5,0.1,0.1,-0.8,-0.0,0.6,0.6,0.0,0.6
2017-03-17,-0.4,1.2,-1.2,0.8,0.8,-1.1,-0.9,-0.2,-0.2,-0.5,-0.3
2017-03-20,0.3,0.7,-0.1,-0.5,-0.5,-0.3,-0.5,0.2,0.3,0.2,0.0
2017-03-21,1.6,2.0,-0.5,-1.4,-1.4,1.1,0.8,1.4,1.6,1.6,1.3
2017-03-22,-0.0,0.3,-0.5,0.1,0.1,0.8,0.4,1.1,1.5,1.5,0.9

2017-03-09: rt AT_USER bay area cos have $500b+ overseas. will AT_USER help bring it home?  $aapl $v $gild $cs¡­|gild potential swing trade - $gild chart |gild potential swing trade $gild |rt AT_USER classic case
2017-03-10: incyte pops on continued gilead takeout speculation $incy $gild  $tsro AT_USER AT_USER AT_USER|$incy baker bros 50% gain ytd for $1.7b* unrealized gain - they'd sell to $gild or whoever the fk that wa
2017-03-11: gilead sciences, inc. $gild rating reiterated by barclays plc |gilead sciences's outperform rating reiterated at barclays plc. $90.00 pt.  $gild #gild|gilead has multiple prospects if it decides to pu
2017-03-12: $gild $incy rumor or not, friday's reaction shows acquisition of literally any company with a decent onc-driven pipepine will lift up $gild|$ibb $gild should be clear to everyone by now that gild got 
2017-03-13: $gild:us  incyte corp. (incy) spiked to a new high on gilead rumors #gilead sciences inc   #nasdaq|$gild $incy AT_USER AT_USER |what a combined gilead and incyte would look like $gild $incy  AT_USER A
2017-03-14: rt AT_USER tuesday - the #trumpdon'tcare health plan fails america $spy $met $gild $lly #esrx --  |rt AT_USER tuesday - the #trumpdon'tcare health plan fails america $spy $met $gild $lly #esrx --  |rt
2017-03-15: $gild possible duplicate of feb low, mm to 72.82 |rt AT_USER great things are happening this year!  like and follow to stay up to date on events, news and more $gild $hadv $gwph|$gild the bull pattern
2017-03-16: #valueinvestor #joelgreenblatt has long position in hated #healthcarestocks. i'm long $gild $bmy $gsk $teva|sold $gild at $112 and bought back in the 70s, close to my original cost basis. long! |$twtr
2017-03-17: $pulm professional fund raising today! they won't want2 crush the stock nor market value4their own good! $gild $twtr great close!|AT_USER yes, that's my blog.  well, $430 out of the premium was a writ
2017-03-18: rt AT_USER $cmxc cell medx corp. : the next big biotech breakthrough could just be on the horizon  $ibb $gi¡­|rt AT_USER $gild within few weeks 76-77 .|connor bruggeman schooltrader made $300,000 and 
2017-03-19: projected weekly ranges in select stocks (mar 20-24): $aapl $agn $amzn $bac $fb $goog $gild $nflx $nvda $tsla $spy¡­ |rt AT_USER first look at projected weekly ranges in select stocks: $aapl $agn $amz
2017-03-20: rt AT_USER $cmxc hot biotech stock to watch right now : cell medx corp.  $ibb $gild $jnj $mrk $nvs $pfe $a¡­|$gild is in macd golden cross winning 60.00% in the past. |3 stocks that are ridiculously c
2017-03-21: #easl #nimbustx $gild progress of lead compound in ph2 nash patients during #ilc2017 |rt AT_USER 5-star analyst geoff meacham from barclays reiterated a buy on $gild.  |5-star analyst geoff meacham fr
2017-03-22: rt AT_USER weakening wednesday - trump agenda begins to unravel  $spy $sds $tasr $gild $tgt --  |rt AT_USER weakening wednesday - trump agenda begins to unravel  $spy $sds $tasr $gild $tgt --  |rt AT_
Answer:
Assess the data and tweets to estimate whether the closing price of $gild will escalate or deflate at 2017-03-23. Respond with either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-03-09,1.2,1.3,-0.8,-1.9,-1.9,1.8,2.3,2.1,1.2,1.8,2.4
2017-03-10,0.6,0.6,-1.1,-0.3,-0.3,1.3,2.3,2.2,1.7,1.9,2.5
2017-03-13,0.3,0.4,-0.8,-0.1,-0.1,0.9,2.1,2.1,1.9,1.8,2.5
2017-03-14,-0.5,0.5,-0.5,-0.5,0.3,0.4,1.5,1.8,1.7,1.3,2.1
2017-03-15,-0.7,0.5,-1.3,1.0,1.0,-0.9,0.3,0.7,0.8,-0.0,0.9
2017-03-16,0.3,0.4,-0.5,0.1,0.1,-0.8,-0.0,0.6,0.6,0.0,0.6
2017-03-17,-0.4,1.2,-1.2,0.8,0.8,-1.1,-0.9,-0.2,-0.2,-0.5,-0.3
2017-03-20,0.3,0.7,-0.1,-0.5,-0.5,-0.3,-0.5,0.2,0.3,0.2,0.0
2017-03-21,1.6,2.0,-0.5,-1.4,-1.4,1.1,0.8,1.4,1.6,1.6,1.3
2017-03-22,-0.0,0.3,-0.5,0.1,0.1,0.8,0.4,1.1,1.5,1.5,0.9

2017-03-09: rt AT_USER bay area cos have $500b+ overseas. will AT_USER help bring it home?  $aapl $v $gild $cs¡­|gild potential swing trade - $gild chart |gild potential swing trade $gild |rt AT_USER classic case
2017-03-10: incyte pops on continued gilead takeout speculation $incy $gild  $tsro AT_USER AT_USER AT_USER|$incy baker bros 50% gain ytd for $1.7b* unrealized gain - they'd sell to $gild or whoever the fk that wa
2017-03-11: gilead sciences, inc. $gild rating reiterated by barclays plc |gilead sciences's outperform rating reiterated at barclays plc. $90.00 pt.  $gild #gild|gilead has multiple prospects if it decides to pu
2017-03-12: $gild $incy rumor or not, friday's reaction shows acquisition of literally any company with a decent onc-driven pipepine will lift up $gild|$ibb $gild should be clear to everyone by now that gild got 
2017-03-13: $gild:us  incyte corp. (incy) spiked to a new high on gilead rumors #gilead sciences inc   #nasdaq|$gild $incy AT_USER AT_USER |what a combined gilead and incyte would look like $gild $incy  AT_USER A
2017-03-14: rt AT_USER tuesday - the #trumpdon'tcare health plan fails america $spy $met $gild $lly #esrx --  |rt AT_USER tuesday - the #trumpdon'tcare health plan fails america $spy $met $gild $lly #esrx --  |rt
2017-03-15: $gild possible duplicate of feb low, mm to 72.82 |rt AT_USER great things are happening this year!  like and follow to stay up to date on events, news and more $gild $hadv $gwph|$gild the bull pattern
2017-03-16: #valueinvestor #joelgreenblatt has long position in hated #healthcarestocks. i'm long $gild $bmy $gsk $teva|sold $gild at $112 and bought back in the 70s, close to my original cost basis. long! |$twtr
2017-03-17: $pulm professional fund raising today! they won't want2 crush the stock nor market value4their own good! $gild $twtr great close!|AT_USER yes, that's my blog.  well, $430 out of the premium was a writ
2017-03-18: rt AT_USER $cmxc cell medx corp. : the next big biotech breakthrough could just be on the horizon  $ibb $gi¡­|rt AT_USER $gild within few weeks 76-77 .|connor bruggeman schooltrader made $300,000 and 
2017-03-19: projected weekly ranges in select stocks (mar 20-24): $aapl $agn $amzn $bac $fb $goog $gild $nflx $nvda $tsla $spy¡­ |rt AT_USER first look at projected weekly ranges in select stocks: $aapl $agn $amz
2017-03-20: rt AT_USER $cmxc hot biotech stock to watch right now : cell medx corp.  $ibb $gild $jnj $mrk $nvs $pfe $a¡­|$gild is in macd golden cross winning 60.00% in the past. |3 stocks that are ridiculously c
2017-03-21: #easl #nimbustx $gild progress of lead compound in ph2 nash patients during #ilc2017 |rt AT_USER 5-star analyst geoff meacham from barclays reiterated a buy on $gild.  |5-star analyst geoff meacham fr
2017-03-22: rt AT_USER weakening wednesday - trump agenda begins to unravel  $spy $sds $tasr $gild $tgt --  |rt AT_USER weakening wednesday - trump agenda begins to unravel  $spy $sds $tasr $gild $tgt --  |rt AT_
Answer:+Fall